The effects of 7 days of exogenous pulsatile GnRH [gonadotropin releasing hormone agonists] treatment on the pituitary gonadal axis in hypogonadotropic hypogonadal subjects.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gonadotropin releasing hormone stimulants
- Indications Hypogonadism; Kallman's syndrome
- Focus Therapeutic Use
- 02 Jul 2021 Biomarkers information updated
- 31 Aug 2010 Planned end date changed from 1 Dec 2012 to 1 May 2015 as reported by ClinicalTrials.gov.
- 20 Aug 2007 New trial record.